Stock listing

REGMF Stock Price, News, Filings & Events — Remegen Co. Ltd. Class A

Selected listing: REGMF · OTC · USD · US

REGMF:OTC represents Remegen Co. Ltd. Class A, a biopharmaceutical company focused on developing innovative therapies for cancer treatment. The company is actively involved in clinical trials and research to advance its product pipeline. Recent news highlights Remegen's progress in regulatory filings and partnerships that may enhance its market position. Investors can stay informed about upcoming events and announcements that could impact the company's growth trajectory.

REGMF:OTCUSDUSUpdated July 21, 2026
Remegen Co. Ltd. Class A logo
Ticker
REGMF:OTC
Asset type
Stock
Market cap
$9.44B
Sector
Health Technology
Industry
Pharmaceuticals: Major
Exchange
OTC
Currency
USD

Remegen Co. Ltd. Class A REGMF:OTC stock context

REGMF:OTC represents Remegen Co. Ltd. Class A, a biopharmaceutical company focused on developing innovative therapies for cancer treatment. The company is actively involved in clinical trials and research to advance its product pipeline. Recent news highlights Remegen's progress in regulatory filings and partnerships that may enhance its market position. Investors can stay informed about upcoming events and announcements that could impact the company's growth trajectory.

Research Remegen Co. Ltd. Class A

Alternate listings